Evidence map›Paper›PMID 25643026›Full record

ArticleExperimental and clinical psychopharmacology2015

Allopregnanolone association with psychophysiological and cognitive functions during acute smoking abstinence in premenopausal women.

Alicia M Allen, Mustafa al'Absi, Harry Lando, Sharon S Allen

Open access · hybridAbstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Clinical Potential of Neurosteroids for CNS Disorders.Trends in pharmacological sciences · 2016
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alicia M AllenDepartment of Family Medicine & Community Health.
Mustafa al'AbsiDepartment of Behavioral Sciences, Medical School, University of Minnesota.
Harry LandoDepartment of Family Medicine & Community Health.
Sharon S AllenDepartment of Family Medicine & Community Health.
University of Minnesota Medical Center · US

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
UNIVERSITY OF MINNESOTA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (UMN CTSI)UL1RR033183 · NCRR · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2011 to 2011
$8.9M
Univ of Minnesota Buidling Interdisciplinary Research Careers in Women's HealthK12HD055887 · NICHD · UNIVERSITY OF MINNESOTA · PI ALLEN, SHARON S, BERGE, JERICA M · 2007 to 2023
$8.6M
TOBACCO CESSATION IN POSTMENOPAUSAL WOMENR01DA008075 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ALLEN, SHARON S · 1993 to 2016
$5.5M
Allopregnanolone in Short-Term Smoking AbstinenceR36DA032539 · NIDA · UNIVERSITY OF MINNESOTA · PI ALLEN, ALICIA M · 2012 to 2012
$26k
NCATS NIH HHS 8UL1TR000114-02NCATS NIH HHS UL1 TR000114NCRR NIH HHS 1UL1RR033183NCRR NIH HHS UL1 RR033183NICHD NIH HHS K12 HD055887NICHD NIH HHS K12HD055887NIDA NIH HHS R01 DA008075NIDA NIH HHS R01-DA08075NIDA NIH HHS R36 DA032539NIDA NIH HHS R36-DA032539
6 · The paper itself

Abstract

Nicotine response may predict susceptibility to smoking relapse. Allopregnanolone, a neuroactive steroid metabolized from progesterone, has been shown to be associated with several symptoms of nicotine response. We sought to explore the association between allopregnanolone and response to nicotine during acute smoking abstinence in premenopausal women. Participants completed 2 nicotine-response laboratory sessions, 1 in their follicular (low allopregnanolone) and 1 in their luteal (high allopregnanolone) menstrual phase, on the fourth day of biochemically confirmed smoking abstinence. During the laboratory sessions, participants self-administered a nicotine nasal spray and completed a timed series of cardiovascular, cognitive, and subjective assessments of response to nicotine. The relationships of allopregnanolone with baseline values and change scores of outcome measures were assessed using covariance pattern modeling. Study participants (N = 77) had a mean age of 29.9 (SD = 6.8) years and smoked an average of 12.2 (SD = 4.9) cigarettes per day. Allopregnanolone concentration measured before nicotine administration was positively associated with systolic (β = 0.85, p = .04) and diastolic blood pressure (β = 1.19, p < .001) and self-report of physical symptoms (β = 0.58, p < .001), dizziness (β = 0.88, p < .01), jitteriness (β = 0.90, p = .04), and pleasantness (β = 2.05, p = .04). Allopregnanolone also had significant positive associations with change in cognition following nicotine nasal spray administration, specifically discriminability as a measure of attention (β = 1.15, p = .05) and response bias as a measure of impulsivity (β = 0.13, p = .02). These data suggest that allopregnanolone may be related to cardiovascular and subjective physical state during acute smoking abstinence, as well as cognitive response to nicotine.

Indexed as

CognitionPremenopauseSmoking CessationAdolescentAdultFemaleHumansPregnanoloneYoung AdultPregnanolone

Identifiers

PMID25643026
PMCPMC4394732
OpenAlexW2326063461

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.